摘要
目的:分析2015年中国前列腺癌的发病与死亡情况,为前列腺癌的防控提供依据。方法:对国家癌症中心收集的全国501个肿瘤登记处上报的2015年数据进行质量审核和评估,将审核合格的数据纳入分析。根据2015年全国人口数据,计算2015年前列腺癌发病和死亡情况,并采用2000年中国标准人口和Segi′s世界标准人口进行标化计算中标率和世标率。结果:经数据审核,368个登记处上报的数据纳入最终分析,共覆盖人口309553499人,占全国2015年年末人口数的22.52%。2015年全国前列腺癌估计新发病例约7.20万例,发病率、中标发病率和世标发病率分别为10.23/10万、6.59/10万和6.47/10万,居男性恶性肿瘤发病谱第6位;估计死亡病例约3.07万例,死亡率、中标死亡率、世标死亡率分别为4.36/10万、2.61/10万和2.65/10万,位居男性恶性肿瘤死亡谱第10位。城市地区中标发病率和中标死亡率分别为8.40/10万和3.11/10万,均远高于农村地区(分别为4.16/10万和1.90/10万);东部地区中标发病率和中标死亡率分别为8.54/10万和2.99/10万,高于中部地区(分别为5.28/10万和2.34/10万)和西部地区(分别为5.32/10万和2.37/10万)。结论:中国前列腺癌的发病率和死亡率低于全球平均水平,但存在升高趋势,且有城乡和地区差异。
Objective To estimate the incidence and mortality rates of prostate cancer in China in 2015.Methods The data from 501 cancer registries in China collected by the National Cancer Center were reviewed and evaluated,and the qualified data were included in the final analysis.According to the national population data in 2015,the nationwide incidence and mortality of the prostate cancer were estimated.Chinese standard population in 2000 and world Segi′s population were used to calculate the age-standardized(ASR)incidence and mortality rates(ASR China and world,respectively).Results After data review,the data reported by 368 registries were included in the final analysis,covering a total population of 309553499,accounting for 22.52%of the national population at the end of 2015.There were 72 thousand new prostate cancer cases estimated in China in 2015,with a crude incidence rate of 10.23/100000.The ASR China and ASR world are 6.59/100000 and 6.47/100000,respectively,which is the sixth incidence of male malignant tumor.The estimated number of prostate cancer death was 3.07 thousand in China in 2015,with a crude mortality rate of 4.36/100000;The ASR China and ASR world mortality rates were 2.61/100000 and 2.65/100000,respectively,which is the tenth leading cause of death in male malignant tumor.The ASR China incidence and mortality of prostate cancer in males were higher in urban areas(8.40/100000 and 3.11/100000)than those in rural areas(4.16/100000 and 1.90/100000).The incidence and mortality rates in the eastern areas(8.54/100000 and 2.99/100000)were higher than those in the central(5.28/100000 and 2.34/100000)and western areas(5.32/100000 and 2.37/100000)of China.Conclusions The incidence and mortality rates of prostate cancer in China are lower than the global average,but there is an increasing trend.The incidence and mortality of prostate cancer in China have obvious regional differences.
作者
付振涛
郭晓雷
张思维
郑荣寿
曾红梅
陈茹
王少明
孙可欣
魏文强
赫捷
Fu Zhentao;Guo Xiaolei;Zhang Siwei;Zheng Rongshou;Zeng Hongmei;Chen Ru;Wang Shaoming;Sun Kexin;Wei Wenqiang;He Jie(Center for Disease Control and Prevention of Shangdong Province,Jinan 250014,China;Cancer Registry Office,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Thoracic Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
2020年第9期718-722,共5页
Chinese Journal of Oncology
基金
中国医学科学院医学与健康科技创新工程(2018-I2M-3-003、2019-I2M-2-004)
国家重点研发计划(2016YFC0901400、2016YFC0901404)
国家自然科学基金(81573224)。
关键词
前列腺肿瘤
发病率
死亡率
肿瘤登记
监测
Prostate neoplasms
Incidence
Mortality
Cancer registry
Surveillance
